To the best of our knowledge, this study was the first clinical trial which evaluated the effects of NS on MDA, TAC, TNF-α, IL-10 and high sensitivity C-reactive protein (hs- CRP) levels in patients with BD. The gene discussed is IL10; the disease is Behcet disease.